nurse at bedside providing multi-organ support for critically ill patient

Filtersets and Catheters for Individualised Acute Therapy

Vantive offers a range of innovative filtersets and catheters to meet the unique needs of critically ill patients.

Enabling multiple therapies

Our various filtersets and catheters enable clinicians to use a single acute therapy system to deliver therapies that manage acute renal failure, fluid overload, and other diseases where the removal of plasma components is indicated. Using the filtersets to administer these therapies, a single system can perform continuous renal replacement therapy, therapeutic plasma exchange, sepsis management and removal of CO₂.

Healthcare professional with patient and family at hospital bedside

CRRT Filtersets

Biocompatible AN69 CRRT filtersets, with a unique adsorptive clearance mechanism, can be used with all CRRT modalities and can support modality change during treatment.

PrismaLung+ Blood Gas Exchanger

The PrismaLung+ blood-gas exchanger enables standalone ECCO₂R therapy or ECCO₂R in combination with CRRT.¹

A healthcare professional supports a patient at the bedside with a PrisMax machine behind her

Oxiris Filterset

Oxiris is the only blood purification filterset to effectively remove inflammatory mediators, endotoxin, fluid, and uremic toxins simultaneously.^2-6

Therapeutic Plasma Exchange (Filtration TPE)

The TPE filterset enables removal of plasma containing abnormal large molecular weight substances and simultaneous infusion of a replacement solution.

GamCath Catheters

The line of GamCath catheters includes Conventional, HighFlow, and Dolphin Protect Coating options to meet the unique needs of adult and paediatric patients in the ICU.

Vantive, AN69, GamCath, Oxiris and PrismaLung+ are trademarks of Vantive Health LLC or its affiliates.

Contact Us

Connect with Vantive to learn more about our filtersets and catheters for individualised acute therapy.

Get in touch

References

PrismaLung+ Indication for Use. 2019.
Turani F, Barchetta R, Falco M, Busatti S, Weltert L. Continuous renal replacement therapy with the adsorbing filter Oxiris in septic patients: a case series. Blood Purif. 2019;47(3):54-58.
Villa G, Romagnoli S, De Rosa S, et al. Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study. Crit Care. 2020;24:605.
Broman ME, Hansson F, Vincent JL, Bodelsson M. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: a randomized crossover double-blind study. PLoS One. 2019;14:e0220444.
Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp. 2018;6:12.
Vantive. Oxiris Instructions for Use. 2022.